Literature DB >> 6383915

Immunological aspect of non-obese diabetic mice: immune islet cell-killing mechanism and cell-mediated immunity.

T Maruyama, I Takei, M Taniyama, K Kataoka, S Matsuki.   

Abstract

The non-obese diabetic mouse is thought to be one of the best available animal models for human Type 1 (insulin-dependent) diabetes. By 51Cr release assay we investigated cell-mediated cytotoxicity to the islet cell of Balb/C mice, natural killer activity, and antibody-dependent cell-mediated cytotoxicity activity of spleen lymphocytes from pre-diabetic non-obese diabetic mice. The cell-mediated cytotoxicity to islet cells of non-obese diabetic mice was significantly higher than that of control ICR mice. In contrast, natural killer and antibody-dependent cell-mediated cytotoxicity activities of the spleen cells from the non-obese diabetic mice were significantly lower than those of ICR mice spleen cells. These results suggest that lymphocytes from non-obese diabetic mice were sensitized to the antigen of islet cells and that the non-specific cellular immunity of non-obese mice was reduced. They suggest also that this immune islet cell-killing mechanism may play an important role in the pathogenesis of diabetes in non-obese diabetic mice.

Entities:  

Mesh:

Year:  1984        PMID: 6383915     DOI: 10.1007/bf00275666

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  8 in total

1.  Block in insulin release from column-perifused pancreatic beta-cells induced by islet cell surface antibodies and complement.

Authors:  T Kanatsuna; A Lernmark; A H Rubenstein; D F Steiner
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

2.  Antibodies direct against the pancreatic islet cell plasma membrane. Detection and specificity.

Authors:  A Lernmark; T Kanatsuna; C Patzelt; K Diakoumis; R Carroll; A H Rubenstein; D F Steiner
Journal:  Diabetologia       Date:  1980-11       Impact factor: 10.122

3.  Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity.

Authors:  S Kataoka; J Satoh; H Fujiya; T Toyota; R Suzuki; K Itoh; K Kumagai
Journal:  Diabetes       Date:  1983-03       Impact factor: 9.461

4.  Insulin-dependent diabetes: a disease of autoaggression.

Authors:  S W Huang; N K Maclaren
Journal:  Science       Date:  1976-04-02       Impact factor: 47.728

5.  Cell-mediated cytotoxic islet cell surface antibodies to human pancreatic beta cells.

Authors:  T Maruyama; I Takei; I Matsuba; A Tsuruoka; M Taniyama; Y Ikeda; K Kataoka; M Abe; S Matsuki
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

6.  Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus.

Authors:  M J Dobersen; J E Scharff; F Ginsberg-Fellner; A L Notkins
Journal:  N Engl J Med       Date:  1980-12-25       Impact factor: 91.245

7.  Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.

Authors:  M A Charles; M Suzuki; N Waldeck; L E Dodson; L Slater; K Ong; A Kershnar; B Buckingham; M Golden
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

8.  Breeding of a non-obese, diabetic strain of mice.

Authors:  S Makino; K Kunimoto; Y Muraoka; Y Mizushima; K Katagiri; Y Tochino
Journal:  Jikken Dobutsu       Date:  1980-01
  8 in total
  9 in total

Review 1.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

2.  Testicular alterations in the nonobese diabetic mouse.

Authors:  Guy W Tarleton; Bernard Gondos; Brent Formby
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

3.  Immunopathology of diabetes in the RT6-depleted diabetes-resistant BB/Wor rat.

Authors:  Z Jiang; E S Handler; A A Rossini; B A Woda
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

4.  Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study.

Authors:  O Pontesilli; P Carotenuto; L S Gazda; P F Pratt; S J Prowse
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

5.  Restriction fragment length polymorphism analysis of major histocompatibility complex genes in the non-obese diabetic mouse strain and its non-diabetic sister strains.

Authors:  Y Fujishima; Y Koide; T Kaidoh; M Nishimura; T O Yoshida
Journal:  Diabetologia       Date:  1989-02       Impact factor: 10.122

6.  The role of cytotoxic macrophages in non-obese diabetic mice: cytotoxicity against murine mastocytoma and beta-cell lines.

Authors:  A Kasuga; T Maruyama; I Takei; A Shimada; T Kasatani; K Watanabe; T Saruta; T Nakaki; S Habu; J Miyazaki
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

Review 7.  Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus.

Authors:  E F Lampeter; A Signore; E A Gale; P Pozzilli
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

8.  Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence.

Authors:  M B Oldstone
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

9.  Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.

Authors:  L S Wicker; B J Miller; L Z Coker; S E McNally; S Scott; Y Mullen; M C Appel
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.